Coya Therapeutics (COYA) Return on Sales (2023 - 2025)
Historic Return on Sales for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to 0.68%.
- Coya Therapeutics' Return on Sales rose 4200.0% to 0.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.99%, marking a year-over-year decrease of 38900.0%. This contributed to the annual value of 4.19% for FY2024, which is 28600.0% down from last year.
- Latest data reveals that Coya Therapeutics reported Return on Sales of 0.68% as of Q3 2025, which was up 4200.0% from 37.25% recorded in Q2 2025.
- Coya Therapeutics' Return on Sales' 5-year high stood at 0.3% during Q4 2023, with a 5-year trough of 2090.32% in Q4 2024.
- Its 3-year average for Return on Sales is 274.76%, with a median of 14.72% in 2025.
- Per our database at Business Quant, Coya Therapeutics' Return on Sales plummeted by -20906200bps in 2024 and then skyrocketed by 115000bps in 2025.
- Over the past 3 years, Coya Therapeutics' Return on Sales (Quarter) stood at 0.3% in 2023, then plummeted by -691308bps to 2090.32% in 2024, then soared by 100bps to 0.68% in 2025.
- Its Return on Sales stands at 0.68% for Q3 2025, versus 37.25% for Q2 2025 and 28.33% for Q1 2025.